January 2012 - PsiOxus Therapeutics strengthens team with two appointments
January 2012 - Early Success of Ark’s Manufacturing Partnership with PsiOxus:Initiation of Toxicology Study for PsiOxus’s ColoAd1 Oncolytic Product
September 2011 - PsiOxus Therapeutics receives £1.8 million translation award from the Wellcome Trust to take Oncolytic Virus into Clinic
March 2011 - Initiation of Clinical Study for MT-102
December 2010 - Launch of PsiOxus Therapeutics
February 2010 - Myotec closes £5.65 million series A funding
December 2009 - Myotec MT-102 pre-clinical data presented at the Society on Sarcopenia, Cachexia and Wasting Diseases, 5th Cachexia Conference in Barcelona
Upcoming Events
September 2012 -Attending ESMO - Vienna, Austria - 28 Sept-02 Oct 2012
June 2012 -Attending Bio International Convention - Boston, USA - 18-21 June 2012
June 2012 -Attending ASCO - Chicago, USA - 01-05 June 2012
April 2012 -Attending BioTrinity 2012 - Newbury, UK - 24-26 Apr 2012
March 2012 -Attending BIO-Europe Spring 2012 - Amsterdam, Netherlands - 19-21 Mar 2012
January 2012 -Presenting at Biotech Showcase 2012 - San Francisco, USA - 09-11 Jan 2012